IDEXX LABORATORIES INC /DE — Director's Dealing 2018

Aug 7, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2018-08-03

Reporting Person: Vandebroek Sophie V. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-08-03	Common Stock	M	2952	$46.91	Acquired	9127	Direct
2018-08-03	Common Stock	S	1515	$240.6418	Disposed	7612	Direct
2018-08-03	Common Stock	M	2986	$64.69	Acquired	10598	Direct
2018-08-03	Common Stock	S	1750	$240.6418	Disposed	8848	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-08-03	Non-Qualified Stock Option (right-to-buy)	$46.91	M	2952	Disposed	2023-08-31	Common Stock (2952)	Direct
2018-08-03	Non-Qualified Stock Option (right-to-buy)	$64.69	M	2986	Disposed	2024-05-06	Common Stock (2986)	Direct

Footnotes

F1: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 3,476 shares on May 7, 2014, without giving effect to the 2-for-1 stock split of IDEXX Laboratories, Inc. common stock that occurred on June 15, 2015 (the "Stock Split"). The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.

F2: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that became exercisable as to 2,987 shares on May 7, 2015, without giving effect to the Stock Split. The number of derivative securities reported as beneficially owned with respect to this option and its exercise price were adjusted to reflect the Stock Split.

F3: Not applicable.